Danazol for treatment of urinary incontinence

Details Danazol for treatment of urinary incontinence Danazol for treatment of urinary incontinence

1992-12-10

1994-08-23

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514177, 514178, A61K 3158, A61K 3156

Patent

active

053408055

ABSTRACT:
The method of use of danazol for reducing or eliminating urinary incontinence and any associated frequent urination in a person suffering therefrom and pharmaceutical compositions therefor are disclosed.

REFERENCES:
patent: 4544555 (1985-10-01), Gastaud
patent: 4908358 (1990-03-01), Schreiber
patent: 4997653 (1991-03-01), Igarsohi
The Merck Index, Eleventh Edition, Merck & Co., Rahway, N.J., Monograph 2811, 1989.
Physicians Desk Reference.RTM., Forty-Sixth Edition, 1992, pp. 2046-2047.
William J. Harrington et al., AIDS Research and Human Retroviruses, vol. 7, No. 12, 1991, pp. 1031-1034.

Affiliated with

Also associated with

Rating

Danazol for treatment of urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Danazol for treatment of urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Danazol for treatment of urinary incontinence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-503169